|
|
|
Volumn 19, Issue 18 SUPPL., 2001, Pages
|
|
Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
METHOTREXATE;
VINBLASTINE;
ADVANCED CANCER;
BLADDER CANCER;
CANCER ADJUVANT THERAPY;
CANCER MORTALITY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYSTECTOMY;
HUMAN;
LYMPH NODE DISSECTION;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
TRANSITIONAL CELL CARCINOMA;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CLINICAL TRIALS, PHASE III;
COMBINED MODALITY THERAPY;
CYSTECTOMY;
DOXORUBICIN;
HUMANS;
METHOTREXATE;
NEOADJUVANT THERAPY;
NEOPLASM INVASIVENESS;
RANDOMIZED CONTROLLED TRIALS;
REPRODUCIBILITY OF RESULTS;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
VINBLASTINE;
|
|
EID: 0035884704
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (17)
|
|
References (8)
|
